计算溶液所需的质量、体积或浓度。
提供 ≥98% 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。
-20°C储存。超低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
Information
INCB054329 INCB054329 (INCB-054329, INCB-54329) is a structurally distinct bromodomain and extraterminal domain (BET) inhibitor with IC50 values of 44 nM, 5 nM, 9 nM, 1 nM, 28 nM, 3 nM, 119 nM and 63 nM for BRD2-BD1, BRD2-BD2, BRD3-BD1, BRD3-BD2, BRD4-BD1, BRD4-BD2, BRDT-BD1 and BRDT-BD2, respectively.
Targets
BRD3-BD2 ; BRD4-BD2 ; BRD2-BD2 ; BRD3-BD1 ; BRD4-BD1 31176,1 nM; 3 nM; 5 nM; 9 nM; 28 nM
In vitro
INCB054329 shows no significant inhibitory activity against 16 non-BET bromodomains at 3 μM. In a panel of 32 hematologic cancer cell lines derived from acute myeloid leukemia, non-Hodgkin lymphoma, and multiple myeloma, the median 50% growth inhibition (GI50) value of INCB054329 is 152 nM (range, 26-5000 nM). In contrast to tumor cell lines, the GI50 value against T cells isolated from non-diseased donors stimulated ex vivo with IL-2 is 2.435 μM. Growth inhibition correlates with a concentration-dependent accumulation of cells in the G1 phase of the cell cycle. INCB054828 is also a selective kinase inhibitor of the FGFR 1, 2, and 3. In myeloma cell lines, treatment with INCB054329 inhibits expression of c-MYC and induced HEXIM1. In both AML and lymphoma cell lines, INCB054329 induces apoptosis consistent with increased expression of pro-apoptotic regulators. INCB054329 reduces expression of Homologous recombination (HR) components and co-operatively reduces cell growth and increases DNA damage and apoptosis induced by PARPi and cisplatin.
In vivo
INCB054329 exhibits high clearance in mice resulting in a short half-life. At exposures that effectively suppressed c-MYC, INCB054329 is found to be efficacious and well tolerated in both the KMS-12-BM and MM1.S xenograft models. oral administration of INCB054329 inhibits tumor growth in several models of hematologic cancers.
Cell Research(from reference)
Cell lines:Myeloma, AML, DLBCL cells
Incubation Time:72 h
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 有机杂环化合物 |
| 类(Class) | 苯并噁嗪类 |
| 亚类(Subclass) | 暂无 |
| 中间层级节点(Intermediate Tree Nodes) | 暂无 |
| 直接上位类(Direct Parent) | 苯并噁嗪类 |
| 其他上位类(Alternative Parents) | 苯并咪唑类 烷基芳基醚 吡啶及其衍生物 N-取代咪唑 苯类化合物 异噁唑 杂芳族化合物 尿素 氧环化合物 氮杂环化合物 有机氮化合物 有机氧化物 碳氢化合物衍生物 |
| 分子骨架(Molecular Framework) | 芳香族杂多环化合物 |
| 取代基(Substituents) | 芳基醚 - 芳香族杂多环化合物 - 氮杂环 - 吡唑 - 苯基化合物 - 苯并咪唑 - 苯并噁嗪 - 乙醚 - 杂芳香族化合物 - 烃衍生物 - 咪唑 - 异噁唑 - N-取代咪唑 - 有机硝基化合物 - 有机氧化物 - 有机氧化合物 - 有机氮化合物 - 有机氧化合物 - 氧杂环 - 吡啶 - 脲 |
| 描述(Description) | 本化合物属于苯并噁嗪类有机化合物。该类化合物具有苯环与噁嗪环(含四个碳原子、一个氧原子及一个氮原子的六元脂肪环)并联的结构特征。 |
| 外部描述符(External Descriptors) | 暂无 |
| ALogP | 1.884 |
|---|---|
| hba_count | 5 |
| HBD Count | 1 |
| Rotatable Bond | 2 |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | I414154 | |
| 分析证书 | I414154 | |
| 分析证书 | I414154 | |
| 分析证书 | I414154 | |
| 分析证书 | I414154 | |
| 分析证书 | I414154 | |
| 分析证书 | I414154 | |
| 分析证书 | I414154 | |
| 分析证书 | I414154 | |
| 分析证书 | I414154 | |
| 分析证书 | I414154 | |
| 分析证书 | I414154 | |
| 分析证书 | I414154 |